Clearmind Medicine Inc. (CMND) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Clearmind Medicine Inc.

NASDAQ: CMND · Real-Time Price · USD
1.00
-0.02 (-1.96%)
At close: Oct 03, 2025, 3:59 PM
1.02
2.00%
After-hours: Oct 03, 2025, 07:58 PM EDT

Clearmind Medicine Cash Flow Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021
Net Income
-4.83M -4.96M -5.25M -7.33M -5.66M -5.87M -6.34M -5.51M -7.1M -9.16M -9.41M -9.82M -8.88M -5.89M -3.9M -1.45M -434.04K -306.93K
Depreciation & Amortization
50.71K 54.48K 51.07K 43.58K 41.8K 33.87K 43.94K 75.78K 122.52K 119.93K 113.38K 80.09K 19.93K 14.71K 2.57K n/a n/a n/a
Stock-Based Compensation
989.74K 1.05M 701.37K 738.75K 362.8K 109.82K 222.6K 488.18K 1.02M 1.44M 1.65M 1.35M 812.53K 356.78K n/a n/a n/a n/a
Other Working Capital
-35.74K 31.38K -197.12K -381.52K -309.17K 317.14K -274.31K -291.62K -7.91K -677.62K 441.42K 37.73K 119.09K -172.21K -317.61K 26.89K -373.29K -18.78K
Other Non-Cash Items
-765.55K -659.25K -263.95K 2.16M 1.17M 1.8M 1.92M 429.79K 1.06M 959.07K 1.22M 1.8M 1.2M 1.45M 1.1M 63.64K 374.73K n/a
Deferred Income Tax
28.52K -122.41K 39.76K 51.11K 77.62K 213.83K 15.75K 4.4K 9.37K 3.42K n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-36.92K -24.53K -132.23K 828.00 -278.48K 614.92K -624.26K 29.37K 1.13M 217.59K 1.69M 358.01K 249.16K -44.74K 25.99K 296.16K -373.78K -51.31K
Operating Cash Flow
-4.57M -4.66M -4.86M -4.33M -4.23M -3.08M -4.7M -4.42M -3.76M -6.38M -5.08M -6.58M -6.63M -4.53M -2.84M -1.15M -807.82K -358.24K
Capital Expenditures
5.67 5.72 -3.28 -7.99 -7.99 -4 n/a -7.59K -7.59K -7.59K -7.59K -221.19K -221.19K -231.19K -231.19K -10K -10K n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-562.75K -362.79K -349.29K -25.7K -25.7K -25.7K -25.7K 63.4K n/a n/a n/a -83.4K -20K -20K -20K n/a n/a n/a
Sales Maturities Of Investments
116.55K 195.06K 112.1K 111.75K 86.26K 7.76K 7.76K 7.76K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-930.24 -908 -908 1.61K -943.59 -943.59 -943.59 -7.53M -7.53M -7.53M -7.53M -20K -20K -20K -20K 4.91K 4.91K 4.91K
Investing Cash Flow
-447.13K -168.63K -238.1K 87.67K 59.62K -53.44K -53.44K 27K -42.15K -7.59K -7.59K -304.59K -241.19K -251.19K -251.19K -5.09K -5.09K 4.91K
Debt Repayment
-44.07K -46.56K -42.59K -31.27K -27.74K -30.16K -39.64K -71.69K -61.75K -46.55K -30.77K n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
362.23K 373K 3.87M 3.89M 3.51M 1.18M -2.32M -2.38M -2.41M -92.72K -92.72K -327.17K 5.33M 7.06M 7.06M 7.32M 1.7M 574.78K
Financial Cash Flow
1.19M 1.34M 6.25M 8.16M 7.67M 8.15M 9.16M 6.83M 6.79M 7.02M 698.4K 792.65K 6.49M 7.36M 7.36M 7.36M 1.73M 753.00
Net Cash Flow
-3.83M -3.5M 1.15M 3.4M 2.98M 4.51M 3.89M 2.4M 2.95M 600.79K -4.42M -6.07M -360.45K 2.6M 4.29M 6.2M 912.63K 235.36K
Free Cash Flow
-4.58M -4.67M -4.87M -4.33M -4.23M -3.08M -4.7M -4.43M -3.77M -6.39M -5.09M -6.8M -6.85M -4.76M -3.07M -1.16M -817.82K -358.24K